The m-rna synthesis service market size has grown strongly in recent years. It will grow from $4.99 billion in 2025 to $5.48 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to acceleration of vaccine research programs, increased funding for genetic research, expansion of contract research services, growing use of mrna in academic studies, improvements in transcription efficiency technologies.
The m-rna synthesis service market size is expected to see strong growth in the next few years. It will grow to $7.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing pipeline of mrna-based therapeutics, rising demand for personalized medicine solutions, expansion of gene therapy research, growing reliance on outsourcing synthesis services, increasing regulatory approvals for mrna products. Major trends in the forecast period include increasing demand for custom mrna constructs, rising adoption of gmp-grade mrna production, growing use of scalable in vitro transcription platforms, expansion of rapid turnaround synthesis services, enhanced focus on high-purity mrna outputs.
The growing emphasis on personalized medicine is expected to drive the growth of the mRNA synthesis service market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and medical decisions based on an individual’s genetic profile, lifestyle, and environment. The rise of personalized medicine is fueled by advancements in genomic sequencing, which allow for more accurate identification of genetic variations associated with disease susceptibility and treatment response. mRNA synthesis services support personalized medicine by enabling the rapid and precise production of mRNA-based therapies tailored to an individual’s genetic profile, facilitating more targeted and effective treatments. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. Among these approvals, seven were cancer drugs, while three targeted other diseases and conditions. Therefore, the growing emphasis on personalized medicine is driving the growth of the mRNA synthesis service market.
Key companies in the mRNA synthesis service market are concentrating on developing innovative technologies, such as RNA polymerase advancements, to improve mRNA synthesis efficiency, yield, and safety. RNA polymerase innovations involve designing advanced enzymes that enhance transcription, reduce side effects such as double-stranded RNA formation, and improve the overall quality of mRNA for vaccines and therapeutics. For instance, in March 2025, Primrose Bio Inc., a US-based biotechnology company, introduced Prima RNApols to boost the efficiency and scalability of mRNA synthesis. This enzyme offers enhanced processivity and high-fidelity transcription, enabling the production of longer and more stable mRNA strands with lower error rates. Its robust performance in in vitro transcription systems reduces impurities and increases overall yield, providing a reliable and scalable solution for companies developing mRNA-based therapeutics. Such innovations are particularly valuable in the expanding field of personalized medicine, where precise and efficient mRNA synthesis is critical.
In December 2024, Novo Holdings A/S, a Denmark-based investment firm, acquired Catalent Inc. for $16.5 billion. This acquisition aims to strengthen Novo Holdings’ presence in the life sciences sector by expanding capabilities in drug development and supply, while promoting sustainable value creation through active ownership. Catalent Inc., based in the US, specializes in providing mRNA synthesis services for therapeutics and vaccines.
Major companies operating in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, APExBIO Technology LLC.
North America was the largest region in the m-RNA synthesis service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the m-rna synthesis service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the m-rna synthesis service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the mRNA synthesis service market by increasing costs of imported enzymes, nucleotides, plasmid DNA materials, bioprocessing equipment, and cleanroom consumables. North America and Europe are most affected due to reliance on specialized imported biochemical inputs, while Asia-Pacific faces cost pressures in scaling GMP manufacturing capacity. These tariffs are raising service pricing and project costs for clients. At the same time, they are driving regional supply chain localization, domestic enzyme production, and increased investment in local mRNA manufacturing infrastructure.
The m-rna synthesis service market research report is one of a series of new reports that provides m-rna synthesis service market statistics, including m-rna synthesis service industry global market size, regional shares, competitors with a m-rna synthesis service market share, detailed m-rna synthesis service market segments, market trends and opportunities, and any further data you may need to thrive in the m-rna synthesis service industry. This m-rna synthesis service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A messenger ribonucleic acid (mRNA) synthesis service refers to the process of producing custom messenger RNA molecules through in vitro transcription based on a supplied deoxyribonucleic acid (DNA) template. These services are applied in areas such as vaccine development, gene therapy, and research in protein expression and functional genomics.
The primary types of mRNA synthesis services include mRNA vaccine synthesis and mRNA drug synthesis. mRNA vaccine synthesis involves producing messenger RNA sequences that instruct cells to produce a specific protein, thereby triggering an immune response to protect against infectious diseases. These services are applied in vaccine development, therapeutic development, research and development, and diagnostics, and are utilized by end users including pharmaceutical companies, biotechnology firms, academic and research institutions, and contract research organizations (CROs).
The mRNA synthesis service market consists of revenues earned by entities by providing services such as template DNA preparation, codon optimization, stability and storage testing, and regulatory support for clinical applications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The m-rna synthesis service market size is expected to see strong growth in the next few years. It will grow to $7.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing pipeline of mrna-based therapeutics, rising demand for personalized medicine solutions, expansion of gene therapy research, growing reliance on outsourcing synthesis services, increasing regulatory approvals for mrna products. Major trends in the forecast period include increasing demand for custom mrna constructs, rising adoption of gmp-grade mrna production, growing use of scalable in vitro transcription platforms, expansion of rapid turnaround synthesis services, enhanced focus on high-purity mrna outputs.
The growing emphasis on personalized medicine is expected to drive the growth of the mRNA synthesis service market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and medical decisions based on an individual’s genetic profile, lifestyle, and environment. The rise of personalized medicine is fueled by advancements in genomic sequencing, which allow for more accurate identification of genetic variations associated with disease susceptibility and treatment response. mRNA synthesis services support personalized medicine by enabling the rapid and precise production of mRNA-based therapies tailored to an individual’s genetic profile, facilitating more targeted and effective treatments. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. Among these approvals, seven were cancer drugs, while three targeted other diseases and conditions. Therefore, the growing emphasis on personalized medicine is driving the growth of the mRNA synthesis service market.
Key companies in the mRNA synthesis service market are concentrating on developing innovative technologies, such as RNA polymerase advancements, to improve mRNA synthesis efficiency, yield, and safety. RNA polymerase innovations involve designing advanced enzymes that enhance transcription, reduce side effects such as double-stranded RNA formation, and improve the overall quality of mRNA for vaccines and therapeutics. For instance, in March 2025, Primrose Bio Inc., a US-based biotechnology company, introduced Prima RNApols to boost the efficiency and scalability of mRNA synthesis. This enzyme offers enhanced processivity and high-fidelity transcription, enabling the production of longer and more stable mRNA strands with lower error rates. Its robust performance in in vitro transcription systems reduces impurities and increases overall yield, providing a reliable and scalable solution for companies developing mRNA-based therapeutics. Such innovations are particularly valuable in the expanding field of personalized medicine, where precise and efficient mRNA synthesis is critical.
In December 2024, Novo Holdings A/S, a Denmark-based investment firm, acquired Catalent Inc. for $16.5 billion. This acquisition aims to strengthen Novo Holdings’ presence in the life sciences sector by expanding capabilities in drug development and supply, while promoting sustainable value creation through active ownership. Catalent Inc., based in the US, specializes in providing mRNA synthesis services for therapeutics and vaccines.
Major companies operating in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, APExBIO Technology LLC.
North America was the largest region in the m-RNA synthesis service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the m-rna synthesis service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the m-rna synthesis service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the mRNA synthesis service market by increasing costs of imported enzymes, nucleotides, plasmid DNA materials, bioprocessing equipment, and cleanroom consumables. North America and Europe are most affected due to reliance on specialized imported biochemical inputs, while Asia-Pacific faces cost pressures in scaling GMP manufacturing capacity. These tariffs are raising service pricing and project costs for clients. At the same time, they are driving regional supply chain localization, domestic enzyme production, and increased investment in local mRNA manufacturing infrastructure.
The m-rna synthesis service market research report is one of a series of new reports that provides m-rna synthesis service market statistics, including m-rna synthesis service industry global market size, regional shares, competitors with a m-rna synthesis service market share, detailed m-rna synthesis service market segments, market trends and opportunities, and any further data you may need to thrive in the m-rna synthesis service industry. This m-rna synthesis service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A messenger ribonucleic acid (mRNA) synthesis service refers to the process of producing custom messenger RNA molecules through in vitro transcription based on a supplied deoxyribonucleic acid (DNA) template. These services are applied in areas such as vaccine development, gene therapy, and research in protein expression and functional genomics.
The primary types of mRNA synthesis services include mRNA vaccine synthesis and mRNA drug synthesis. mRNA vaccine synthesis involves producing messenger RNA sequences that instruct cells to produce a specific protein, thereby triggering an immune response to protect against infectious diseases. These services are applied in vaccine development, therapeutic development, research and development, and diagnostics, and are utilized by end users including pharmaceutical companies, biotechnology firms, academic and research institutions, and contract research organizations (CROs).
The mRNA synthesis service market consists of revenues earned by entities by providing services such as template DNA preparation, codon optimization, stability and storage testing, and regulatory support for clinical applications. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. m-RNA Synthesis Service Market Characteristics
3. m-RNA Synthesis Service Market Supply Chain Analysis
4. Global m-RNA Synthesis Service Market Trends and Strategies
5. m-RNA Synthesis Service Market Analysis of End Use Industries
7. Global m-RNA Synthesis Service Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global m-RNA Synthesis Service Total Addressable Market (TAM) Analysis for the Market
9. m-RNA Synthesis Service Market Segmentation
10. m-RNA Synthesis Service Market Regional and Country Analysis
11. Asia-Pacific m-RNA Synthesis Service Market
12. China m-RNA Synthesis Service Market
13. India m-RNA Synthesis Service Market
14. Japan m-RNA Synthesis Service Market
15. Australia m-RNA Synthesis Service Market
16. Indonesia m-RNA Synthesis Service Market
17. South Korea m-RNA Synthesis Service Market
18. Taiwan m-RNA Synthesis Service Market
19. South East Asia m-RNA Synthesis Service Market
20. Western Europe m-RNA Synthesis Service Market
21. UK m-RNA Synthesis Service Market
22. Germany m-RNA Synthesis Service Market
23. France m-RNA Synthesis Service Market
24. Italy m-RNA Synthesis Service Market
25. Spain m-RNA Synthesis Service Market
26. Eastern Europe m-RNA Synthesis Service Market
27. Russia m-RNA Synthesis Service Market
28. North America m-RNA Synthesis Service Market
29. USA m-RNA Synthesis Service Market
30. Canada m-RNA Synthesis Service Market
31. South America m-RNA Synthesis Service Market
32. Brazil m-RNA Synthesis Service Market
33. Middle East m-RNA Synthesis Service Market
34. Africa m-RNA Synthesis Service Market
36. m-RNA Synthesis Service Market Competitive Landscape and Company Profiles
37. m-RNA Synthesis Service Market Other Major and Innovative Companies
40. m-RNA Synthesis Service Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
m-RNA Synthesis Service Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses m-rna synthesis service market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for m-rna synthesis service? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The m-rna synthesis service market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: mRNA Vaccine Synthesis; mRNA Drug Synthesis2) By Application Area: Vaccine Development; Therapeutic Development; Research and Development; Diagnostics
3) By End-user Industry: Pharmaceutical Companies; Biotechnology Firms; Academic And Research Institutions; Contract Research Organizations (CROs)
Subsegments:
1) By mRNA Vaccine Synthesis: Infectious Disease Vaccines; Cancer Vaccines; Personalized Vaccines2) By mRNA Drug Synthesis: Protein Replacement Therapies; Gene Editing Therapeutics; Cell Therapy Support
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; AGC Biologics Inc.; Eurofins Scientific SE; Lonza Group AG; Catalent Inc.; Samsung Biologics Co. Ltd.; WuXi Biologics (Cayman) Inc.; GenScript Biotech Corporation; Azenta Inc.; Genewiz Inc.; New England Biolabs Inc.; TransGen Biotech Co. Ltd.; Creative Biolabs Inc.; Bioneer Corporation; Aldevron LLC; eTheRNA immunotherapies NV; Bio-Synthesis Inc.; TriLink BioTechnologies LLC; APExBIO Technology LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this m-RNA Synthesis Service market report include:- Thermo Fisher Scientific Inc.
- Danaher Corporation
- AGC Biologics Inc.
- Eurofins Scientific SE
- Lonza Group AG
- Catalent Inc.
- Samsung Biologics Co. Ltd.
- WuXi Biologics (Cayman) Inc.
- GenScript Biotech Corporation
- Azenta Inc.
- Genewiz Inc.
- New England Biolabs Inc.
- TransGen Biotech Co. Ltd.
- Creative Biolabs Inc.
- Bioneer Corporation
- Aldevron LLC
- eTheRNA immunotherapies NV
- Bio-Synthesis Inc.
- TriLink BioTechnologies LLC
- APExBIO Technology LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.48 Billion |
| Forecasted Market Value ( USD | $ 7.9 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
